Cargando…

Meta-Analysis of Modulated Electro-Hyperthermia and Tumor Treating Fields in the Treatment of Glioblastomas

SIMPLE SUMMARY: Glioblastoma is a highly aggressive brain tumor, which has a very poor 5-year survival rate (<5%). In the last decades, the concomitant use of two non-invasive, electromagnetic devices, modulated electro-hyperthermia (mEHT) and Tumor Treating Fields (TTF) has been introduced. Both...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szasz, Attila Marcell, Arrojo Alvarez, Elisabeth Estefanía, Fiorentini, Giammaria, Herold, Magdolna, Herold, Zoltan, Sarti, Donatella, Dank, Magdolna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913117/ https://www.ncbi.nlm.nih.gov/pubmed/36765840 http://dx.doi.org/10.3390/cancers15030880

Ejemplares similares

Longitudinal Analysis of 1α,25-dihidroxyvitamin D(3) and Homocysteine Changes in Colorectal Cancer
por: Mühl, Dorottya, et al.
Publicado: (2022)

Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer?
por: Dank, Magdolna, et al.
Publicado: (2022)

Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancer
por: Herold, Zoltan, et al.
Publicado: (2022)

Modulated Electro-Hyperthermic (mEHT) Treatment in the Therapy of Inoperable Pancreatic Cancer Patients—A Single-Center Case-Control Study
por: Petenyi, Flora Greta, et al.
Publicado: (2021)

Evidence based tools to improve efficiency of currently administered oncotherapies for tumors of the hepatopancreatobiliary system
por: Herold, Zoltan, et al.
Publicado: (2021)

High plasma CD40 ligand level is associated with more advanced stages and worse prognosis in colorectal cancer
por: Herold, Zoltan, et al.
Publicado: (2022)

Comparison of the effectiveness of integrative immunomodulatory treatments and conventional therapies on the survival of selected gastrointestinal cancer patients
por: Kleef, Ralf, et al.
Publicado: (2023)

Influence of the duration of type 2 diabetes mellitus on colorectal cancer outcomes
por: Herold, Magdolna, et al.
Publicado: (2023)

Review of the Clinical Evidences of Modulated Electro-Hyperthermia (mEHT) Method: An Update for the Practicing Oncologist
por: Szasz, Attila M., et al.
Publicado: (2019)

Commentary on "Systematic review about complementary medical hyperthermia in oncology" by Liebl et al.
por: Arrojo, Elisabeth, et al.
Publicado: (2022)

Prolonged hyperthermic intraperitoneal chemotherapy duration with 90 minutes cisplatin might increase overall survival in gastric cancer patients with peritoneal metastases
por: Steinhoff, Heinrich, et al.
Publicado: (2023)

Patients with Metachronous Peritoneal Metastatic Mucinous Colorectal Adenocarcinoma Benefit More from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) than Their Synchronous Counterparts
por: Herold, Zoltan, et al.
Publicado: (2022)

Personalized Indicator Thrombocytosis Shows Connection to Staging and Indicates Shorter Survival in Colorectal Cancer Patients with or without Type 2 Diabetes
por: Herold, Zoltan, et al.
Publicado: (2020)

High Tumor-Infiltrating Lymphocyte Count Is Associated with Distinct Gene Expression Profile and Longer Patient Survival in Advanced Ovarian Cancer
por: Barna, Andras Jozsef, et al.
Publicado: (2023)

Quo Vadis Oncological Hyperthermia (2020)?
por: Lee, Sun-Young, et al.
Publicado: (2020)

The Prediction Analysis of Microarray 50 (PAM50) Gene Expression Classifier Utilized in Indeterminate-Risk Breast Cancer Patients in Hungary: A Consecutive 5-Year Experience
por: Dank, Magdolna, et al.
Publicado: (2023)

Histopathological Chromogranin A-Positivity Is Associated with Right-Sided Colorectal Cancers and Worse Prognosis
por: Herold, Zoltan, et al.
Publicado: (2020)

Modulated electro-hyperthermia in stage III and IV pancreatic cancer: Results of an observational study on 158 patients
por: Fiorentini, Giammaria, et al.
Publicado: (2021)

Does diabetes affect paraneoplastic thrombocytosis in colorectal cancer?
por: Herczeg, Gyorgy, et al.
Publicado: (2022)

The Clinical Validation of Modulated Electro-Hyperthermia (mEHT)
por: Lee, Sun-Young, et al.
Publicado: (2023)

Modulated Electro-Hyperthermia as Palliative Treatment for Pancreatic Cancer: A Retrospective Observational Study on 106 Patients
por: Fiorentini, Giammaria, et al.
Publicado: (2019)

Deconstructing Immune Cell Infiltration in Human Colorectal Cancer: A Systematic Spatiotemporal Evaluation
por: Ágoston, Emese Irma, et al.
Publicado: (2022)

Morphological and pathological response in primary systemic therapy of patients with breast cancer and the prediction of disease free survival: a single center observational study
por: Szentmártoni, Gyöngyvér, et al.
Publicado: (2016)

Serum chromogranin A level continuously rises with the progression of type 1 diabetes, and indicates the presence of both enterochromaffin‐like cell hyperplasia and autoimmune gastritis
por: Herold, Zoltan, et al.
Publicado: (2020)

Re: Response to Recommendation of Regional Hyperthermia in the Treatment of Breast Cancer
por: Fiorentini, Giammaria, et al.
Publicado: (2021)

A Narrative Review of Regional Hyperthermia: Updates From 2010 to 2019
por: Fiorentini, Giammaria, et al.
Publicado: (2020)

Suppression of Metastatic Melanoma Growth in Lung by Modulated Electro-Hyperthermia Monitored by a Minimally Invasive Heat Stress Testing Approach in Mice
por: Thomas, Mbuotidem Jeremiah, et al.
Publicado: (2020)

Lower serum chromogranin B level is associated with type 1 diabetes and with type 2 diabetes patients with intensive conservative insulin treatment
por: Herold, Zoltan, et al.
Publicado: (2020)

New therapeutic approaches for type 1 diabetes: Disease-modifying therapies
por: Nagy, Geza, et al.
Publicado: (2022)

Oncological hyperthermia: The correct dosing in clinical applications
por: Lee, Sun-Young, et al.
Publicado: (2018)

Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
por: Acs, Miklos, et al.
Publicado: (2022)

Modulated Electrohyperthermia in Integrative Cancer Treatment for Relapsed Malignant Glioblastoma and Astrocytoma: Retrospective Multicenter Controlled Study
por: Fiorentini, Giammaria, et al.
Publicado: (2018)

Hyperthermia combined with chemotherapy vs chemotherapy in patients with advanced pancreatic cancer: A multicenter retrospective observational comparative study
por: Fiorentini, Giammaria, et al.
Publicado: (2023)

Correlation between Expression Profiles of Key Signaling Genes in Colorectal Cancer Samples from Type 2 Diabetic and Non-Diabetic Patients
por: Elek, Zsuzsanna, et al.
Publicado: (2020)

In vitro comparison of conventional hyperthermia and modulated electro-hyperthermia
por: Yang, Kai-Lin, et al.
Publicado: (2016)

Updates of colorectal cancer liver metastases therapy: review on DEBIRI
por: Fiorentini, Giammaria, et al.
Publicado: (2020)

Opposite prognostic roles of HIF1α and HIF2α expressions in bone metastatic clear cell renal cell cancer
por: Szendrői, Attila, et al.
Publicado: (2016)

Methyl Donors Reduce Cell Proliferation by Diminishing Erk-Signaling and NFkB Levels, While Increasing E-Cadherin Expression in Panc-1 Cell Line
por: Kiss, Eva, et al.
Publicado: (2022)

Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy
por: Tsang, Yuk-Wah, et al.
Publicado: (2015)

Modulated Electro-Hyperthermia Resolves Radioresistance of Panc1 Pancreas Adenocarcinoma and Promotes DNA Damage and Apoptosis In Vitro
por: Forika, Gertrud, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_du46oel4i01rid744kkcvr5181